Will Hepatitis C Virus Medicaton Costs Drop in the Years Ahead?

The high cost of hepatitis C virus (HCV) drugs has caused significant financial strain for patients and the health care system. These drugs cost as much as $95,000 for a 12-week treatment, but carry a 90% or better cure rate, which many believe justifies the cost. While some insurers have implemented cost containment strategies to prevent early stage patients from receiving the treatment, lawsuits have been filed challenging the ethics of these practices.

U.S.: Hillary Clinton calls out drug maker Gilead over price of hepatitis C pills

WASHINGTON, Aug. 18 (UPI) -- Democratic presidential nominee Hillary Clinton said Wednesday her administration will go after drug companies that charge exorbitant prices, singling out the company Gilead, whose hepatitis C drugs cost between $900 and $1,000 per pill in the United States. Gilead's hepatitis C drug cures what had been a chronic liver condition diagnosed in more than 3 million Americans that can lead to increased risk of cirrhosis and liver c

U.S.: More bad news for hep C drug pricing

The majority of state Medicaid programs cannot afford hepatitis C medications, such as Harvoni and Sovaldi (Gilead Sciences), which can cost nearly $100,000 for a single course of treatment.Thirty-three states spent more than $1 billion a year to treat the disease with Sovaldi, according to data released by Senators Charles Grassley (R-Iowa), and Ron Wyden (D-Ore.). That meant that only treat 2.4% of Medicaid patients who were infected with the hep C virus

U.S.: Lawmaker: Costly hepatitis C drug “a slap in the face to the veterans”

A Congressional hearing will begin Wednesday in response to a CBS News investigation that showed how a costly new cure for hepatitis C isn't making it to most of the 200,000 U.S. veterans infected with the disease, many as a result of their service. Congress has given $2.7 billion taxpayer to treat veterans with hepatitis C, but only 15 percent have been treated with the drug, one that might not exist without government funding.The drug at the center of We

Pamela Anderson Cured of Hepatitis C But Others Wait for Miracle Drug

Anderson said the treatment cost around $100,000 and was covered by her health insurance. Healthy once more, Anderson is back focusing on projects like her cooking show and vegan shoe line.But not everyone is so lucky.Shima Andre, a 42-year-old Hepatitis C sufferer living in California, has health insurance and was prescribed an alternate version of the drug called Harvoni, but she was originally denied coverage after her disease was not deemed advanced en

Pricey hepatitis C drugs threaten health care system

When does Big Pharma profiting become profiteering? This issue was the subject last month of a Senate Finance Committee investigation of pricing practices of Gilead Sciences Inc., a leading provider of hepatitis C medications. After examining 20,000 pages of internal company documents, looking at Medicaid data and interviewing health care experts, the authors concluded that the Foster City drugmaker “pursued a calculated scheme for pricing and marketing it

The drug that costs more than $1200, and sells for $5 in India

The same hepatitis C drug that costs $US1000 in the US costs just $US4 in India. Outsiders don't want their daughters to marry any local boys, according to the village elders swapping stories in a tailor's shop behind the Sikh temple, because most residents are infected with "black jaundice".That's what they call hepatitis C, which is so common in parts of India's Punjab state that the tailor-shop gossips might not be off base in their estimate. But preval

Sofosbuvir/daclatasvir combination could be produced for $200 per hepatitis C cure

Month-by-month tracking of the prices paid in India for the chemicals used to make hepatitis C direct-acting antivirals shows that it is now possible to make and sell a combination of drugs to cure hepatitis C for less than $200, Dr Andrew Hill of Liverpool University told the Second European HIV Hepatitis Co-infection Conference in London last week.If those drugs were bought at list price in the United States they would cost approximately $147,000 for a 1

Maker of $1,000 hepatitis C pill put profit before patients: U.S. Senate

WASHINGTON -- The makers of a breakthrough drug for hepatitis C put profits before patients in pricing the $1,000 pill that cures the liver-wasting disease, Senate investigators said Tuesday.A bipartisan report from the Senate Finance Committee concluded that California-based Gilead Sciences was focused on maximizing revenue even as the company's own analysis showed a lower price would allow more patients to be treated.Although the report focused on just o